American International Group’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,549
Closed -$63.2K 1280
2024
Q1
$63.2K Sell
6,549
-55
-0.8% -$637 ﹤0.01% 2719
2023
Q4
$54.9K Buy
6,604
+650
+11% +$3.77K ﹤0.01% 2797
2023
Q3
$49.7K Buy
5,954
+212
+4% +$1.8K ﹤0.01% 2819
2023
Q2
$53K Buy
5,742
+636
+12% +$7.13K ﹤0.01% 2870
2023
Q1
$70.2K Buy
5,106
+102
+2% +$2.11K ﹤0.01% 2610
2022
Q4
$85.1K Sell
5,004
-19
-0.4% -$380 ﹤0.01% 2582
2022
Q3
$114K Buy
5,023
+339
+7% +$6.84K ﹤0.01% 2476
2022
Q2
$84K Buy
4,684
+612
+15% +$10.9K ﹤0.01% 2693
2022
Q1
$109K Sell
4,072
-286
-7% -$5.33K ﹤0.01% 2561
2021
Q4
$128K Sell
4,358
-56
-1% -$2.78K ﹤0.01% 2614
2021
Q3
$290K Sell
4,414
-105
-2% -$8.03K ﹤0.01% 2205
2021
Q2
$376 Buy
4,519
+155
+4% +$11.5K ﹤0.01% 2108
2021
Q1
$335 Buy
4,364
+239
+6% +$21.8K ﹤0.01% 2067
2020
Q4
$364 Sell
4,125
-120
-3% -$8.44K ﹤0.01% 1930
2020
Q3
$313K Sell
4,245
-96
-2% -$5.68K ﹤0.01% 1850
2020
Q2
$317K Buy
4,341
+1,410
+48% +$85.7K ﹤0.01% 1840
2020
Q1
$165K Sell
2,931
-171
-6% -$7.5K ﹤0.01% 2008
2019
Q4
$118K Buy
+3,102
New +$77.9K ﹤0.01% 2525

Other funds holding IGMS

American International Group's IGMS Position: Q2 2024 in Review

American International Group sold out of IGM Biosciences (IGMS) in Q2 2024, closing a stake of 6,549 shares — an estimated $63.2K sold.

American International Group first reported a position in IGMS in Q4 2019 and held it in 18 quarters. The position peaked at $317K in Q2 2020. 82 funds tracked by Wall St. Rank hold IGMS as of Q2 2024.

  • American International Group reported no remaining IGM Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 6,549 IGM Biosciences shares in Q2 2024, an estimated $63.2K.
  • American International Group first reported a position in IGM Biosciences in Q4 2019 and held it in 18 quarters.
  • American International Group's IGM Biosciences position peaked at $317K in Q2 2020.
  • 82 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.